University of Gothenburg
Professor Nils Lycke is the director of Mucosal Immunobiology & Vaccines (MIVAC) and head of the Department of Clinical Immunology at the Sahlgrenska University Hospital in Gothenburg, Sweden. He is the principal investigator of several internationally recognized projects focused on Mucosal Immunity and Tolerance where he is a leading researcher in the field. He has published over 180 original peer-reviewed papers and 35 reviews or book chapters. Lycke et. al. have pioneered the development of mucosal vaccines with important contributions to the field in adjuvant construction, including the patented CTA1-DD adjuvant. Basic mechanism of mucosal immune regulation, vaccine development and clinical assessment of safety & efficacy are other main research areas. He has been the coordinator of 5 EU-sponsored projects and receives financial support from EU, NIH, Wellcome Trust, Swedish Cancer foundation, KAW , The Strategic Research Foundation and the Swedish Research Council, and others.